Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis

Background: The use of direct oral anticoagulant (DOAC) off-label doses in atrial fibrillation (AF) patients may result in poor clinical outcomes. However, the true prevalence remains scarce. This study aims at estimating the prevalence of DOAC off-label doses in AF patients. Methods: Databases of M...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Nan-Nan, Zhang, Chi, Hang, Ying, Li, Zheng, Kong, Ling-Cong, Wang, Na, Wang, Jia-Liang, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188240/
https://www.ncbi.nlm.nih.gov/pubmed/34122056
http://dx.doi.org/10.3389/fphar.2021.581293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188240/
https://www.ncbi.nlm.nih.gov/pubmed/34122056
http://dx.doi.org/10.3389/fphar.2021.581293

Ejemplares similares